Friday, April 17, 2015

 

08:30-10:00

DILEMMAS IN HARD-TO-TREAT INFECTIONS IN CHILDREN  -  Hall A

Capsule 

The management of central catheter-related infections, tubercolosis and congenital infections are hard to

eradicate and raise significant dilemmas

Chairperson
Sharon NachmanUSA
   
 08:30-09:00

The management of central catheter-related infections

Itzhak Levy, Israel

 09:00-09:30

Diagnosis and treatment of tuberculosis

Sharon Nachman, USA

 09:30-10:00

Controversies in congenital Cytomegalovirus Infection: From pregnancy to infancy

Efraim Bilavsky, Israel


08:30-10:00

RISK FACTORS FOR ASTHMA DEVELOPMENT IN CHILDREN  -  Hall B

Chairpersons
Sami Bahna, USA
 
Helen Chan, Hong Kong
   
 08:30-09:00

Is the prevalence of respiratory allergies really rising? Evidence and causes

Giovanni Viegi, Italy

 09:00-09:30

Pre and post-natal exposures effect on asthma development

Stefania La Grutta, Italy

 09:30-10:00

Role of air pollution in asthma and allergic rhinitis

Giovanni Viegi, Italy


08:30-10:00
NUTRITION  -  Hall C
Capsule Infant nutrition has an impact not only during childhood but also on the long term health including adulthood.  In this session, the new developments in infant nutrition will be discussed.  In addition, there will be a debate about the benefits and deleterious effect of cow milk.  We will discuss to who and how much cow milk is beneficial and when to avoid cow milk
Chairperson
Shimon Reif, Israel
 08:30-09:00
Update on infant nutrition
Shlomi Cohen, Israel
 09:00-10:00
Debate: 
 
Is milk a friend or a foe in human nutrition?
 
Friend: Shimon Reif, Israel
 
Foe: Shlomi Cohen, Israel
 
Discussion
 
 10:00-10:20
Coffee Break
 

 10:20-11:50

PROBLEMS IN ANTIBIOTIC TREATMENT IN CHILDREN  -  Hall A

 Capsule
Antibiotic therapy, which has changed the whole medical practice, is currently complicated. The increasing antibiotic resistance of bacteria and new data on pathogenesis and virulence mechanisms should be considered in choosing the right antibiotic with the right dose for the right duration
 Chairperson
Irja LutsarEstonia
 10:20-10:50
Antibiotic therapy: Choosing the right dose for the right duration in 2015
Irja Lutsar, Estonia
 10:50-11:20
Controversies in the field of febrile infants aged 3 months or less
Efraim Bilavsky, Israel
 11:20-11:50
Debates in group A streptococcal infections in children
Sharon NachmanUSA

 10:20-11:50

NON-TRADITIONAL ALLERGY MANAGEMENT  -  Hall B

 Chairpersons
Sami Bahna, USA
 
Giovanni Viegi, Italy
   
 10:20-10:50 

Traditional Chinese medicine for allergy

Helen Chan, Hong Kong

 10:50-11:20 

Pediatric eczema: The natural vs. the synthetic

Amal Assa’ad, USA

 11:20-11:50 

Are inhaled corticosteroids effective in acute asthma?

Marina Atanaskova-Markovic, Serbia


 10:20-11:50
GLUTEN SENSITIVITY  -  Hall C
   
 Chairpersons
Gabor Veres, Hungary
 
Ilma Korponay-Szabo, Hungary
    
 10:20-10:50

Introduction

Ilma Korponay-SzaboHungary

 10:50-11:50 

Debate: Gluten sensitivity is a distinct entity

Yes:Jernej Dolinsek, Slovenia

No:Ilma Korponay-Szabo, Hungary

Discussion

 

 11:50-12:10 Poster viewing

 12:10-13:40

INDUSTRY SYMPOSIUM  -  Hall A

 13:40-14:30

Lunch break


 14:30-16:00

THE IMMUNOCOMPROMISED CHILD  -  Hall A

 Capsule

The increasing numbers of immunocompromised children in modern pediatrics raises significant challenges and dilemmas. The treatment of children with AIDS and the approach to their viral infections deserve consideration 

 Chairperson
Itzhak LevyIsrael
 14:30-14:40
Introduction
Itzhak Levy, Israel
 14:40-15:20 
Pediatric HIV and AIDS
Sharon NachmanUSA
 15:20-16:00 
Management of RSV infections in immunocompromized children
Itzhak LevyIsrael

 14:30-16:00

RATIONAL THERAPEUTICS I  -  Hall B

 Chairpersons
Eyal Cohen, Canada
Denis Scolnik, Canada
 14:30-15:00 
Controversies in treating pneumonia
Eyal Cohen, Canada
 15:00-15:15 

Discussion

 15:15-15:45 
Treatment of strep throat: Frequency and duration of antibiotics
Denis Scolnik, Canada
 15:45-16:00 

Discussion

 14:30-16:00

PROBIOTICS  -  Hall C

 Capsule

During the last few years, more and more controlled and well-designed studies have demonstrated the therapeutic value of probiotics in the neonate, toddler and child. Yet, pediatricians are often hesitant in updating their practice to include probiotics. This session will present the evidence for the effective and safe use of probiotics, with a focus on neonatal colics

 Chairperson

Gideon Koren, Canada

 14:30-15:00 
Systematic review on the use of probiotics in pedatric allergic rhinitis
Deborah Kennedy, Canada
 15:00-15:30 
A randomized trial of Lactobacillus vs. placebo in infantile colic
Kim Chau, Canada
15:30-16:00 
Methodological challenges in studying probiotics in children
Gideon KorenCanada
 
 16:00-16:30
Coffee break

 16:30-18:00

THE VACCINE CONTROVERSY IN 2015  -  Hall A

 Capsule

The development of safe and efficacious vaccines against infectious diseases, using innovative technologies, is certainly one of the most important achievements of modern medicine. However, at no point in the past has vaccine opposition been so widespread and problematic 

 Chairperson
Shai AshkenaziIsrael
 16:30-17:00

Introduction
Shai Ashkenazi, Israel 

 17:00-17:30  
Novel vaccines: From trial-and-error to science
Shai Ashkenazi, Israel
 17:30-18:00 
Ethical, social and legal issues regarding immunization
Adam FinnUK

 16:30-18:00
RATIONAL THERAPEUTICS II  -  Hall B
   
 Chairpersons

Gideon Koren, Canada

Eyal Cohen, Canada

 16:30-17:00 

Nicotine replacement therapy during pregnancy

Gideon Koren, Canada

 17:00-17:15  Discussion

 17:15-17:45 

Does anything work in changing the natural history of viral bronchiolitis?

(Emphasis on the epinephrine/dexamethasone question)

Eyal Cohen, Canada

 17:45-18:00  Discussion

 16:30-18:00
EOSINOPHILIC DISORDERS  -  Hall C
 Capsule
Although several studies in children and adults support considering eosinophilic esophagitis a form of food allergy, the usefulness of skin-prick testing and atopy patch testing for food allergies and the optimal elimination diet for disease management are still uncertain
 Chairpersons
Rok Orel, Slovenia
Gábor Veres, Hungary
 16:30-17:00 
Common and rare causes of blood eosinophils
Christina Hauer, Austria
 17:00-17:30 
Eosinophilic esophagitis
Rok Orel, Slovenia
 17:30-18:00 
Eosinophilic colitis
Gábor Veres, Hungary

Saturday, April 18, 2015

 08:30-10:00

PEDIATRIC ADHD: OVER OR UNDER DIAGNOSED?  -  Hall A

 Capsule

The complexities of Attention Deficit Hyperactivity Disorder (ADHD) diagnostic process is the subject of much debate including the cultural bias effect, the limitations of the DSM definitions, the effect of comorbid conditions, and the gene-environment interactions. There is a need to compose an objective, more accurate, and generally accepted diagnostic battery of tests.This lecture reviews the aims and challenges in providing adequate diagnosis, addresses the diagnostic difficulties of ADHD and considers some steps that would make ADHD a more easily identifiable disorder

 Chairpersons
Itai Berger, Israel
David Coghill, UK
 08:30-09:00 
ADHD Diagnosis: Much ado about something
Itai Berger, Israel
 09:00-10:00 

Debate: Pediatric ADHD is over diagnosed

Proposition:François Gonon, France

Opposition:David Coghill, UK

Discussion


 08:30-10:00

CHILDREN WITH RECURRENT INFECTIONS  -  Hall B

 Chairpersons

Stefania La Grutta, Italy

Marina Atanaskovic-Markovic, Serbia
   
 08:30-09:00 

How useful is the history and physical examination in diagnosing immunodeficiency?

Sami Bahna, USA

 09:00-09:30 

How deep can you look into the immune system?

Amal Assa’ad, USA

 09:30-10:00 

Case discussions: What is this immunodeficiency?

Sami Bahna, USA

 

 

 08:30-10:00

CONTROVERSIES IN BACTERIAL INFECTIONS IN CHILDREN  -  Hall C

 Capsule

Human bacteria can be commensal, causing no harm or virulent with significant morbidity and mortality. What makes commensals into pathogens and how should we treat them?

 Chairperson
Adam FinnUK
 08:30-09:00 
S. pneumoniae is a commensal; What makes it into a pathogen?
Adam FinnUK
 09:00-09:30 
The treatment of MRSA and MRSE infections in children
Shai Ashkenazi, Israel
 09:30-10:00 
The approach to neonatal bacterial infections
Irja LutsarEstonia
 10:00-10:20
Coffee break

 

 

 10:20-11:50

EPILEPSY: WEST SYNDROME - Hall A

 Capsule

There is no consensus on the best treatment for patients with West syndrome. Steroids and Sabril (Vigabatrin) are the preferred drugs. The beneficial effects as well as the side effects of both medications are discussed in this session 

 Chairperson
Uri Kramer, Israel
 10:20-10:50 
West syndrome: An evil epileptic encephalopathy
Olivier Dulac, France
 10:50-11:50 
DebateWhat is the best treatment for West syndrome?
ACTH is the treatment: Uri Kramer, Israel
Vigabatrin is as good and much safer: Colin Ferrie, UK
Discussion

 10:20-11:50

DRUGS AND FOOD ALLERGY  -  Hall B

 Chairpersons
Sami Bahna, USA
 
Amal Assa’ad, USA
   
 10:20-10:50 

Can allergies occur to multiple drugs from different classes?

Marina Atanaskovic-Markovic, Serbia

 10:50-11:20 

Are food allergies forever or self-limited?

Helen Chan, Hong Kong

 11:20-11:50 

Allergic rhinitis in children: Burden and impact on quality of life

Stefania La Grutta, Italy


 10:20-11:50

NEONATOLOGY  -  Hall C

 Capsule

Drug therapy is a powerful tool for improving neonatal outcome. Despite this, neonatologists still routinely prescribe off-label compounds developed for adults and extrapolate doses from those used for children or adults. Knowledge integration through pharmacokinetic modeling is a method that could improve the current situation. Such predictive models may convert neonatal pharmacotherapy from explorative to confirmatory

 Chairperson
John Van Den Anker, USA
 10:20-10:50  
Neonatal clinical pharmacology in 2015
Karel Allegaert, Belgium
 10:50-11:50 

Debate: Therapeutic drug monitoring of aminoglycosides and vancomycin

Useful:Karel Allegaert, Belgium

Useless:John Van Den Anker, USA

Discussion

 11:50-12:10 Poster viewing

 12:10-13:40

Free Communication - Oral Presentations  -  Hall A

 12:10-12:25 Role of host and environment risk factors for asthma by gender
Giovanna Cilluffo, Italy
 12:25-12:40 Electromagnetic radiation generating device use and low birth weight in sakarya province in Turkey
Dilek Kose, Turkey
 12:40-12:55

Intrapulmonary vascular anastomoses in fatal neonatal lung disorders associated with pulmonary hypertension
Csaba Galambos, USA

 12:55-13:10

anti-angiogenic factors contribute to the pathomechanism of lung hypoplasia and pulmonary hypertension in infants and children with Down Syndrome
Csaba Galambos, USA

 13:10-13:25

Preoperative examination before adenoidectomy and tonsillectomy: Medical history or laboratory tests?
Daniel Groh, Czech Republic

 13:25-13:40

The knowledge, perception and practice of female circumcision among mothers in Malaysia
Rafidah Hanim Mokhtar, Malaysia


 12:10-13:40
NUTRITION: THE FIRST 1000 DAYS - Hall B
 Capsule

Many questions arise regarding the importance of various components of nutrition in the first 1000 days of life. One of them is: whether probiotics improve feeding tolerance leading to better overall growth

 Chairpersons

Dénes Molnár, Hungary
András Arató, Hungary
Jorge Amil Dias, Portugal

 12:10-12:40
Food and formula in allergy prevention in the first 1000 days
Jorge Amil Dias, Portugal
 12:40-13:10   
Hungary: The first 1000 days and role of protein intake
Dénes Molnár, Hungary 
 13:10-13:40 
Significance of pre- and probiotics in the allergy prevention in the first 1000 days
András Arató, Hungary

12:10-13:40

ITP: NOVEL THERAPY  -  Hall C

Capsule

There is no clear consensus regarding second-line therapies for the treatment of ITP that do not respond to first-line therapies in the acute setting and in the chronic phase. Rituximab is a useful second-line therapy and may be splenectomy-sparing. Thrombopoeitin receptor agonists have demonstrated large treatment effects with respect to increasing platelet levels; however, they require maintenance dosing

Chairpersons
Thomas Kuehne, Switzerland
Paul Imbach, Switzerland
 12:10-12:40 
Immunomodulation in ITP
Falk Nimmerjahn, Germany
 12:40-13:40 

Debate: TPA versus Rituximab in clinical use for ITP

For TPA: Nicola CooperUK

For Rituximab: Bertrand Godeau, France

Discussion

   
 13:40-14:30 Lunch break

 14:30-16:00

NEW GENERATION SEQUENCING  -  Hall A

 Capsule

The next generation sequencing has provided a new model originating from sequencing data to genetic disease study, and has made a revolutionary change in the strategy of gene identification for genetic diseases. Due to the application of next generation sequencing technology, gene identification has been accelerated in recent years, and moreover, the new technology and strategy helps in genetic counseling and prenatal diagnosis

 Chairpersons
Arnold Munnich, France
Dorit Lev, Israel
 14:30-15:00 
New generation sequencing: A new diagnostic tool
Arnold Munnich, France
 15:00-16:00 

Debate: New generation sequencing: The ultimate method in genetics?

Pro:Dorit Lev, Israel

Con:Arnold Munnich, France

Discussion


 14:30-16:00

ENTERAL NUTRITION SUPPORT (ENS): A CONTROVERSY IN ITSELF! - Hall B

 Capsule
Whilst in most cases, the intended nutritional goals are the main indication for PEG-placement and subsequent nutritional rehabilitation, very little is known about the recommended duration of the intervention, support for transitioning to oral feeds and allied issues to take care of. The analysis of the side effects in a very large sample of tube dependent children like oral aversion, recurrent vomiting, reflux, food refusal, gagging and retching as well as malnutrition must be taken into consideration as well as the evaluation of the quality and duration of feeding attempts, and the impact of stressful and ineffective feeding into the parent-child relationship. The overall goal is looking at a bigger picture of ENS in early childhood
 Chairpersons
Marguerite Dunitz-Scheer, Austria
Avi Mizrahi, Israel
 14:30-15:00 
Nutritional AND non-nutritional aspects and issues contributing to ENS being a clear benefit for nutritional rehabilitation
Marguerite Dunitz-Scheer, Austria
 15:00-15:15 
Discussion
 15:15-15:45 

Presentation of 3 medically fragile toddlers receiving temporary ENS over months after intensive care
Avi Mizrahi, Israel

 15:45-16:00 

Discussion


 14:30-16:00

Free Communication - Oral Presentations  -  Hall C

 14:30-14:45 Evaluation of heart murmur referrals made to a one stop paediatric cardiology service at a district general hospital
Pooja Sarkar, UK
 14:45-15:00 Constipation in operated patients due to Anorectal Malformations
Sejdi Statovci, Albania
 15:00-15:15

Histological healing of intestinal lesions after infliximab induction treatment is associated with sustained clinical remission in pediatric patients with Crohn's disease
Edyta Szymanska, Poland

 15:15-15:30

Lymphocyte Potassium channel inhibition as a novel therapeutic approach in pediatric Crohn's disease
Gergely Toldi, Hungary

 15:30-15:45

Why do children and their parents participate in medical research? Results from a qualitative interview study
Krista Tromp, Netherlands

 15:45-16:00

The effect of pre-intervention practices on pain and anxiety related to peripheral cannulation processes in children
Pinar Tunc Tuna, Turkey


 16:30-18:00

PEDIATRIC VASCULITIS  -  Hall A

 Capsule

Kawasaki disease is an acute systemic vasculitis of childhood. Due to the development of coronary artery aneurysms, it is considered the most common cause of acquired heart disease in children

 Chairperson
Rolando Cimaz, Italy
 16:30-17:30 

Debate: Corticosteroids in vasculitis

Pros:Jordi Anton, Spain

Cons:Michael Hofer, Switzerland

Discussion

 17:30-18:00
Update on Kawasaki disease
Rolando CimazItaly

 
 16:30-18:00

JUVENILE IDIOPATHIC ARTHRITIS (JIA)  -  Hall B

 Chairpersons
Francesco Zulian, Italy

Tamas Costantin, Hungary
   
 16:30-17:00 

Old and new treatments for JIA

Francesco Zulian, Italy

 17:00-18:00 

Debate: Role of corticosteroids, indications for second line drugs and biotherapies,

timing of treatment discontinuation

Tamas Costantin, Hungary

Tadej Avcin, Slovenia

Discussion


 

 16:30-18:00

 

RESEARCH GROUPS -  Hall C

 Capsule

Although relatively common, the management of febrile infants aged <2 months varies considerably among medical institutions, as it is a highly debatable issue. We have performed a national survey of all 25 inpatient pediatric hospitals in Israel on the practices of fever evaluation of febrile infants aged ≤60 days (Acta Paediatrica 2014; 103:379-85). We plan now to proceed to an international survey.

Gender medicine is not familiar to most pediatricians.  Gender differences are not the focus in most of the studies in pediatrics.  Response to treatment and side effects of medications may emphasize gender differences.  Adolescents may serve as an appropriate population for this scope

 Chairpersons
Ami Ballin, Israel
Shai Ashkenazi, Israel

Sunday, April 19, 2015

 08:30-10:00

PRE-ENT SURGERY EXAMINATIONS  -  Hall A

 Capsule

The value of routine coagulation testing instead of bleeding history alone in children, to predict bleeding risk prior to tonsillectomy and adenoidectomy has been questioned. Costs and health outcome states are addressed

 Chairpersons
Shoshana Revel-Vilk, Israel
Ami Ballin, Israel
 08:30-09:00 
Pre-ENT surgery examinations
Groh Daniel, Czech Republic
 09:00-10:00 

Debate: Should we screen children for coagulopathies pre-ENT surgery?

Pro: Shoshana Revel-VilkIsrael

Con: Ami Ballin, Israel

Discussion


 08:30-10:00

RATIONAL THERAPEUTICS III  -  Hall B

 Chairpersons
Gideon Koren, Canada
Denis Scolnik, Canada

 08:30-09:00

 09:00-09:15

Pain relief for children with surgical diagnoses in the ED
Denis Scolnik, Canada
Discussion

 09:15-09:45

 09:45-10:00 

Using opioid narcotics for pain after tonsillectomy in children with obstructive sleep apnea
Gideon Koren, Canada
Discussion

10:00-10:30            Coffee Break  

 
 10:30-12:00
 
CELIAC DISEASE  -  Hall A
 Capsule
Recently more accurate diagnostic tests for the diagnosis of celiac disease were developed.  They include: tissue trans glutaminase (TTG), endomysial (EMA), and deaminated gliadine peptise (DGP) antibiodies as well as genetic test e.g. HLA.  Therefore, this discussion will focus on whether there is still a role of duodenal biopsy for the diagnosis of celiac disease in children
 Chairperson

Shimon Reif, Israel

 10:30-11:30 
 

Debatels duodenal biopsy mandatory for the diagnosis of celiac disease?

Yes:Shimon Reif, Israel

No:Shlomi Cohen, Israel

Discussion 

 
 11:30-12:00 
A practical approach for the evaluation of abnormal liver enzymes in children
Shimon Reif, Israel
 
 10:30-12:00 INFLAMMATORY BOWEL DISEASE -  Hall B
 Chairpersons
 
Paolo Lionetti, Italy
Jiri Bronsky, Czech Republic
 10:30-11:00 
What is the topic?
Paolo Lionetti, Italy
 11:00-11:30 
Biosimilars in pediatric Crohn disease: Pro and Con
Daniela Serban, Romania
 11:30-12:00 
Future therapeutic options in inflammatory bowel disease
Jiri Bronsky, Czech Republic